DIAMEDICA THERAPEUTICS INC (DMAC)

CA25253X2077 - Common Stock

2.59  +0.06 (+2.37%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
0.000.000.000.000.00
Operating Expenses
21.27M14.00M13.65M12.70M11.59M
Research and Development
13.11M7.84M8.77M8.31M7.90M
Selling, General, and Administrative Expenses
8.16M6.16M4.88M4.39M3.69M
Operating Income
-21.27M-14.00M-13.65M-12.70M-11.59M
Interest Income/Expense
N/AN/AN/AN/A0.00
Other Income/Expense
1.93M350.00K80.00K430.00K980.00K
Non Recurring Items
N/AN/AN/AN/AN/A
Income Before Taxes
-19.34M-13.65M-13.56M-12.27M-10.62M
Income Tax
43.00K30.00K30.00K30.00K30.00K
Net Income
-19.38M-13.68M-13.59M-12.29M-10.65M
EBITDA
-21.24M-13.97M-13.63M-12.68M-11.57M
 
Per Share Data
EPS Diluted Total Ops
-0.60-0.52-0.65-0.78-0.89
Non GAAP EPS
-0.62-0.52-0.64-0.78-0.89
 
Statistics
Profit Margin
N/AN/AN/AN/AN/A
Operating Profit Margin
N/AN/AN/AN/AN/A

All data in USD

Charts